濮阳东方医院评价高专业-【濮阳东方医院】,濮阳东方医院,濮阳市东方医院咨询免费,濮阳东方医院看男科口碑好很放心,濮阳东方妇科口碑怎么样,濮阳东方医院割包皮很正规,濮阳东方看妇科收费很低,濮阳东方妇科医院价格比较低
濮阳东方医院评价高专业濮阳东方男科医院咨询医生在线,濮阳东方医院治疗早泄评价很不错,濮阳东方看男科病技术好,濮阳东方妇科医院电话多少,濮阳东方看妇科口碑好收费低,濮阳东方男科医院割包皮手术评价,濮阳东方医院妇科口碑高吗
SAN FRANCISCO, Sept. 13 (Xinhua) -- Microsoft released on Tuesday a test version of Windows 8 to developers, posing to regain ground of the tablet market dominated by Apple and Google.At its developer-focused BUILD conference held in Anaheim, California, the software giant handed out new Samsung tablet computers with a test version of the code-named "Windows 8," the first detailed preview of the system for developers and people outside Microsoft.Generally expected to be launched in fall 2012, Microsoft did not say when the system will ship or its price.Microsoft Windows President Steven Sinofsky introduces the new tablet running a test version of its touch-enabled Windows 8 at the Build conference in Anaheim, California September 13, 2011Featuring a home page filled with colorful application tiles, the new system boots up in seconds. Microsoft said the system will run on low-power ARM-based chips that power smartphones and tablets. Windows 8 also introduces a new "Metro style" interface, which run full-screen and users can multitask in two at a time."We reimagined Windows," said Steven Sinofsky, president of the Windows and Windows Live Division at Microsoft, in his keynote address to the thousands of developers in attendance. "From the chipset to the user experience, Windows 8 brings a new range of capabilities without compromise."Analysts said the new system is consumer-oriented and intuitive but it will take time to see whether it is an "iPad killer."As professionals and consumers began to spend more time on smartphones and tablets, Microsoft has not got a significant bite of the market, losing ground to Apple's iPad and devices running Google's Android system.
WELLINGTON, Sept. 27 (Xinhua) -- New Zealand and Japanese scientists are teaming up to develop healthier foods under two government-funded "functional foods" projects.One project, to be led by New Zealand's Massey University, will work with New Zealand food companies to create and develop a functional food with specific health enhancing effects for menopausal women, New Zealand Science and Innovation Minister Wayne Mapp announced Tuesday.The other project, to be led in New Zealand by Plant and Food Research, would use mass spectrometry to develop a "metabolic atlas" of the chemical composition of allium vegetables, such as onions and garlic, which the horticultural industry could use to develop new food products with health benefits.Mapp said the two research projects would be awarded a total of 1 million NZ dollars (782,000 U.S. dollars) in funding to strengthen collaborative research relationships between New Zealand and Japan, Mapp said."These research projects have strong commercial potential, including through the Japanese market, and so have the potential to benefit our economy," said Mapp."The government is committed to building and strengthening research relationships with other countries that will achieve world-class scientific results and lead to new innovative technologies."The two projects awarded funding under Ministry of Science and Innovation's Japan Science and Technology Agency (JST) funding round focus on functional foods. The ministry and Japan each fund half the cost of each research project awarded funding.
BEIJING, Aug 4 (Xinhuanet) – A new urine test might help doctors detect prostate cancer and better evaluate a patient's treatment options, according to American reseachers Thursday."This is a tool that men and their physician can use to help them decide whether it's appropriate to get a biopsy now or delay that decision," said lead researcher Dr. Scott Tomlins, a pathology resident at the University of Michigan Health System.The test looks for two genetic markers associated with prostate cancer. The first, called TMPRSS2:ERG, is caused by two genes changing places and fusing together; it is thought to cause prostate cancer. Since the gene fusion is only seen in about half of cancer patients, the test also looks for another marker, called PCA3."We are exploiting some new bio-markers to try to refine the PSA (prostate-specific antigen) test," Tomlins said.
SAN FRANCISCO, Aug. 9 (Xinhua) -- Nokia is planning to stop selling its low-end phones and smartphones in the United States, instead focusing on products using Microsoft's Windows Phone platform, U.S. media reported on Tuesday.The Finnish handset maker will end sales of its low-end Series 40 phones and smartphones based on the Symbian mobile operating system in the United States and Canada, as it needs to put all of its efforts into the Windows Phone products which are due out later this year, Chris Weber, head of Nokia's U.S. subsidiary, told technology news site All Things Digital."When we launch Windows Phones we will essentially be out of the Symbian business, the S40 business, etc.," Weber said.Staff members speak to trade visitors at the Nokia booth at the CommunicAsia expo in Singapore June 21, 2011.In February, Nokia and Microsoft announced plans to form a broad strategic partnership, under which Nokia agrees to adopt Windows Phone as its principal smartphone strategy.North America is a priority for Nokia, Weber noted, in part because it is a key market for Microsoft and also because Nokia sees it as a key to winning in the smartphone battle globally."We'll develop for North America and make the phones globally available and applicable," Weber said.In another development, technology blog Engadget and other U.S. media on Tuesday reported that Nokia will not bring N9, its first smartphone running the Linux-based mobile operating system MeeGo, to the U.S. market."After the very positive reception to the launch of the Nokia N9, the product is now being rolled out in countries around the world. At this time we will not be making it available in the U.S., " Nokia said in a statement.